Martin D Madaus is of Quanterix Corp. Currently has a direct ownership of 29,473 shares of QTRX, which is worth approximately $389,633. The most recent transaction as insider was on Jan 02, 2024, when has been sold 2,947 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.5K
0% 3M change
11.11% 12M change
Total Value Held $389,633

Martin D Madaus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
2,947 Added 9.09%
29,473 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
8,083 Added 23.36%
26,526 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
$65,645 $21.21 p/Share
3,095 Added 14.37%
18,443 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
$18,118 $51.18 p/Share
354 Added 2.25%
15,348 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
$18,082 $59.48 p/Share
304 Added 1.99%
14,994 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
$18,066 $61.45 p/Share
294 Added 1.96%
14,690 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
$59,121 $22.06 p/Share
2,680 Added 15.69%
14,396 Common Stock
Nov 05 2020
SELL
Open market or private sale
$58,241 $42.45 p/Share
1,372 Reduced 10.48%
11,716 Common Stock
Nov 05 2020
BUY
Exercise of conversion of derivative security
$3,128 $2.28 p/Share
1,372 Added 9.49%
13,088 Common Stock
Nov 04 2020
SELL
Open market or private sale
$63,040 $39.4 p/Share
1,600 Reduced 12.02%
11,716 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$3,648 $2.28 p/Share
1,600 Added 10.73%
13,316 Common Stock
Oct 20 2020
SELL
Open market or private sale
$68,112 $42.57 p/Share
1,600 Reduced 12.02%
11,716 Common Stock
Oct 20 2020
BUY
Exercise of conversion of derivative security
$3,648 $2.28 p/Share
1,600 Added 10.73%
13,316 Common Stock
Oct 19 2020
SELL
Open market or private sale
$71,344 $44.59 p/Share
1,600 Reduced 12.02%
11,716 Common Stock
Oct 19 2020
BUY
Exercise of conversion of derivative security
$3,648 $2.28 p/Share
1,600 Added 10.73%
13,316 Common Stock
Oct 07 2020
SELL
Open market or private sale
$59,472 $37.17 p/Share
1,600 Reduced 12.02%
11,716 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$3,648 $2.28 p/Share
1,600 Added 10.73%
13,316 Common Stock
Oct 06 2020
SELL
Open market or private sale
$58,352 $36.47 p/Share
1,600 Reduced 12.02%
11,716 Common Stock
Oct 06 2020
BUY
Exercise of conversion of derivative security
$3,648 $2.28 p/Share
1,600 Added 10.73%
13,316 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
$18,044 $34.7 p/Share
520 Added 4.25%
11,716 Common Stock
Sep 29 2020
SELL
Open market or private sale
$52,240 $32.65 p/Share
1,600 Reduced 12.5%
11,196 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$3,376 $2.11 p/Share
1,600 Added 12.37%
11,338 Common Stock
Sep 28 2020
SELL
Open market or private sale
$52,944 $33.09 p/Share
1,600 Reduced 12.5%
11,196 Common Stock
Sep 28 2020
BUY
Exercise of conversion of derivative security
$3,088 $1.93 p/Share
1,600 Added 11.11%
12,796 Common Stock

Also insider at

RGEN
REPLIGEN CORP Healthcare
AZTA
Azenta, Inc. Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
MDM

Martin D Madaus

Billerica, MA

Track Institutional and Insider Activities on QTRX

Follow Quanterix Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QTRX shares.

Notify only if

Insider Trading

Get notified when an Quanterix Corp insider buys or sells QTRX shares.

Notify only if

News

Receive news related to Quanterix Corp

Track Activities on QTRX